All news from Anaesthesiology

New Proteins Targeting Small Molecules

First such advance makes possible creation of new beta-barrel proteins to precisely target small molecules. For the first time, scientists have created, entirely from scratch,  a protein capable of binding to a small target molecule. The study was published in the journal Nature.

Nursing Homes Increasingly Pushing Residents Into ‘unnecessary’ Rehab At End-of-Life

A new study contends that nursing homes may be pushing dying patients into unnecessary and potentially harmful high-intensity rehab services. Providers defended the system Wednesday. University of Rochester Medical Center researchers noted that the number of residents receiving “ultra-high” rehab services in New York state increased by 65% during the three-year period ending in 2015.

Most of those services were delivered to individuals in the last seven days of their lives, according to the analysis of data from 647 nursing homes in the Empire State that was published this week in the Journal of the American Medical Directors Association.

Less Cost Ventilator For ICU Patients

A team of specialists in various fields have come up with a less costly ventilator for patients in Intensive Care Units (ICUs) to address its scarcity which leads to an unwanted increase in mortality rates. According to the Philippine Council for Health Research and Development of the Department of Science and Technology (PCHRD-DOST), 50% of ICU patients need a ventilator.

In many developing countries like the Philippines, there is only 1 ventilator per 10 ICU beds due to the prohibitive cost of acquiring a ventilator plus the inaccessibility of spare parts when it breaks. These factors pose a challenge for small hospitals to acquire more units.

FDA Approves New Lotion For Acne Treatment

The new lotion spreads easily and is quickly absorbed by the skin, making it an attractive option for many patients suffering from acne. The U.S. Food and Drug Administration has approved Ortho Dermatologic’s new drug application for Altro (tretinoin 0.05%) lotion for the treatment of acne vulgaris.

Approved for use in patients ages nine and older, the formulation is the first of its kind in a lotion, according to a company news release. It is expected to be on the market by the fourth quarter of 2018.